Stock ANL ADLAI NORTYE LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Adlai Nortye Ltd.

Equities

ANL

US00704R1095

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
3.71 USD -13.52% Intraday chart for Adlai Nortye Ltd. -48.90% -58.73%
May. 24 Adlai Nortye Ltd. Announces to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy At ASCO 2024 CI
May. 22 Adlai Nortye Announces First Patient Dosed in Randomized Phase Ii Clinical Trial of Palupiprant for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ADLAI NORTYE LTD.
Other Biotechnology & Medical Research
-13.52%-48.90%-58.73% - - 137M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ANL Stock
  4. Charts Adlai Nortye Ltd.
  5. Comparison Chart